Contact
Please use this form to send email to PR contact of this press release:
FDA expands approved use of Kalydeco to treat additional mutations of cystic fibrosis
TO:
Please use this form to send email to PR contact of this press release:
FDA expands approved use of Kalydeco to treat additional mutations of cystic fibrosis
TO: